Nine Diagnostics

📍 Cambridge, United States🗓 Founded 2024👥 3 employees💰 Last funded Feb 2025
Determining treatment effectiveness, discovering new biology using AI enabled nanosensor technology. A faster path to the most effective treatment with better outcomes. We develop holistic profiles based on a patients personal health data, demographics, social determinants of health, and other relevant factors pertinent to the ultimate outcomes. Multidimensional datasets are acquired from fluorescent emissions using an array of nanoscale sensing elements that detect health abnormalities and signals of treatment effectiveness in small patient samples.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Nine Diagnostics?
Nine Diagnostics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Nine Diagnostics last raise funding?
The most recent investment in Nine Diagnostics recorded on gritt.io was in February 2025.
When was Nine Diagnostics founded?
Nine Diagnostics was founded in 2024.
What industry is Nine Diagnostics in?
Nine Diagnostics operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is Nine Diagnostics based?
Nine Diagnostics is headquartered in Cambridge, United States.